ARTICLE | Clinical News
Ritalin LA once-daily extended release methylphenidate capsules regulatory update
October 8, 2001 7:00 AM UTC
CELG and partner Novartis AG (NVS; SWX:NOVN, Basel, Switzerland) received an approvable letter from the FDA for Ritalin LA to treat attention deficit hyperactivity disorder (ADHD). Ritalin LA uses fo...